Cambridge Healthtech Institute’s Inaugural

Antibody-Based Cancer Therapies

Recent Advances and Future Directions

14 November 2023


The success of monoclonal antibodies as a therapeutic class for cancer has given rise to the development of various types of therapeutic antibodies, including nanobodies, antibody scaffolds, bispecific and multi-specific antibodies, antibody-drug conjugates, immunocytokines, etc. At the same time, cell-based therapy has emerged as a promising immunotherapy approach to cancer and non-antibody approaches such as mRNAs, oligonucleotides, cancer vaccines, etc., are increasingly gaining momentum. The Antibody-Based Cancer Therapies conference aims to showcase the latest and hottest in these therapeutic approaches, inviting speakers to discuss their mechanisms, engineering, preclinical to clinical translation, and combination strategies.

Coverage will include, but is not limited to:

  • Emerging New Antibodies and Antibody Derivates for Cancer Treatment
    • Nanobodies/Single-domain antibodies
    • Bispecific/Bi-paratopic antibodies
    • Multi-specific and multi-valent antibodies
    • Antibody-Drug Conjugates, Peptide-Drug Conjugates, Degrader-Antibody Conjugates
    • Masked antibodies/ Conditionally-activated antibodies
    • PROTACs and molecular glues
    • Immunocytokines
  • Next-Generation Cell-Based Therapies
    • CARs – CAR T, CAR M, CAR NK
    • TILs
    • TCRs
  • Non-Antibody Therapies
    • mRNA/DNA
    • Antisense Oligonucleotides
    • Cancer Vaccines

The deadline for priority consideration is 31 March 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:

For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439
Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com